Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s80239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Metastatic Non-Small Cell Lung Cancer in Brazil: Treatment Heterogeneity in Routine Clinical Practice

Clinics
Medicine
2007English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy